The neuroprogressive nature of major depressive disorder: Pathways to disease evolution and resistance, and therapeutic implications
Version 2 2024-05-30, 15:35Version 2 2024-05-30, 15:35
Version 1 2014-10-28, 09:43Version 1 2014-10-28, 09:43
journal contribution
posted on 2024-05-30, 15:35 authored by Steve MoylanSteve Moylan, M Maes, NR Wray, Michael BerkMichael BerkThe neuroprogressive nature of major depressive disorder: Pathways to disease evolution and resistance, and therapeutic implications
History
Journal
Molecular PsychiatryVolume
18Pagination
595-606Location
EnglandISSN
1359-4184eISSN
1476-5578Language
EnglishPublication classification
C1 Refereed article in a scholarly journalCopyright notice
2012, Nature Publishing GroupIssue
5Publisher
NATURE PUBLISHING GROUPPublication URL
Usage metrics
Categories
No categories selectedKeywords
Science & TechnologyLife Sciences & BiomedicineBiochemistry & Molecular BiologyNeurosciencesPsychiatryNeurosciences & Neurologycytokinesdepressioninflammationneuroprogressionnitrosative stressoxidative stressNITRIC-OXIDE SYNTHASENEUROTROPHIC FACTOR EXPRESSIONSUBGENUAL PREFRONTAL CORTEXMEDIATED IMMUNE ACTIVATIONLIPID-PEROXIDATION PRODUCTSTRESS-INDUCED DEPRESSIONMETHYL-D-ASPARTATEHIPPOCAMPAL VOLUMEOXIDATIVE STRESSDOUBLE-BLIND119999 Medical and Health Sciences not elsewhere classified970111 Expanding Knowledge in the Medical and Health Sciences
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC